MSB - Mesoblast Limited

[SuperGlue]

Re: MSB - Mesoblast

Is Cell Therapy the 'Future of Medicine'?: Jason Kolbert

Mesoblast discussed in the interview - quite a long interview.

http://www.thelifesciencesreport.com/pub/na/15472

Please DYOR

 

[SuperGlue]

Re: MSB - Mesoblast

Link to a write up for Biotech stocks:

http://www.thebull.com.au/premium/a/42153-7-biotech-stocks-with-bounding-share-prices.html


Please DYOR.

 

[crossroads]

Mesoblast

Hey there, has anybody got a view on the latest with MSB? its in a trading halt pending a listing on the Nasdaq

 

[piggybank]

Re: MSB - Mesoblast

Link to a write up for Biotech stocks:

http://www.thebull.com.au/premium/a/42153-7-biotech-stocks-with-bounding-share-prices.html

Please DYOR.

Personally, I prefer reports/research on companies (especially Biotechs) more recent than this one!!

​

It appears my sarcasm is "outdated" by the fact that the report submitted by SuperGlue was actually only released a few days earlier, so I apologize to him and I will have my eyes checked out.

Although I have read and heard (via Foxtel - Your Money, Your Shares) quite a bit about the stock, it doesn't appear to be "loved" here!!

 

[rryall]

MSB up over 10% today on news of its licensee in Japan, JCR Pharmaceuticals, has received notification that the Japanese Government’s National Health Insurance (NHI) body has formally set the price for the mesenchymal stem cell product TEMCELL, effective from today.

I think timing of announcement was done for the benefit of AUS investors since US markets are closed due to thanksgiving. I've bought a smallish parcel today due to price and announcement and holding for long term. Anyone else following this stock?

 

[skyQuake]

That nasdaq listing has been quite a disaster! Japan news was very promising (though actually out yesterday).
Today had M&G funds increasing its holdings which would provide a nice chunk of optimism for many.

 

[skc]

That nasdaq listing has been quite a disaster! Japan news was very promising (though actually out yesterday).
Today had M&G funds increasing its holdings which would provide a nice chunk of optimism for many.

For some reason ASX investors always have the idea that a foreign exchange listing will be awesome... stock will be re-rated, manipulators will be gone etc etc. LNC was a classic. BOTA (the old Biota) was another one. I struggle to think of any company changing home resulting in any of these wishes.

Let see if MSB can shake off the terrible start on Nasdaq.

 

[barman76]

Hi. Anyone following msb and me so now???

 

[qldfrog]

a few shares but not enough to follow closely

 

[mcgrath111]

I currently hold MSB and follow it some what closely.

Believe that the company holds strong prospects, however as with stem cell therapy it's a very speculative stock.
An ASX announcement has just released the trial size can be substantially reduced for the treatment of heart failure. This should be recognized as positive news, however is down 4% - likely due to market sentiment overall.

MSB is continuing to burn through cash, however in the coming months announcements in regards to different treatments will hopefully prove successful and buck the negative downtrend MSB has faced recently.

The above being said, it's really a hard stock to value, and whether stem cell therapy will ever take off (Even though the potential is there).
As previously reading through an ASX update, the cost of temcell etc. is extremely expensive for the patient.

 

[Mofra]

This one has been on the watchlist for a while (glad I didn't buy when higher, very tempted to) - finally spiking due to the release of "bags" in Japan and phase 3 trial commencement in the US.

Hard to price this one (as per all biotechs) but has it finally turned the corner? Chartists might like the mini-breakout but need to confirm momentum.

 

[UMike]

I got these @ $2 on the way down.... Really wondering when to jump off this ship.

 

[Knobby22]

I'm on board now.
I just like all the 3 phase trials taking place and the markets they are entering including inflammation, lower back pain, and todays announcement regarding the heart. Price has doubled recently. I believe the worm has turned.

 

[PeterJ]

multiple entries have been presented on MSB in the past few months
with a $3 target offered early this week
sold half

 

[tech/a]

How was $3 as a target calculated?

Why sell only half if that was the target?

What do you expect from here --- why?

 

[PeterJ]

$3 was a previous resistance level on the chart,
and a round $ value, psychological point and
a good place to lock in 2R +
the remainder will run with a trailing stop should the trend continue

Peter

 

[tech/a]

Thanks
I've played it a little differently.

Good plan

 

[Cam019]

Ascending triangle forming. I'd be looking for a breakout and close above $3.01.

 

[tech/a]

Still in it

 

[PeterJ]

Ascending triangle forming. I'd be looking for a breakout and close above $3.01.

View attachment 70786

Have been watching this consolidation closely and
the close above $3.01 yesterday
triggered my buy order
which added to my current position
Peter